Steramist is the only system in the world capable of a 99.9999% kill of Covid-19. It was developed by DARPA as a result of the 2001 United States biological attack using weaponised anthrax known as Amerithrax.

1. Approved Group International
2019-nCoV (COVID-19)
2020
Steramist

2. Summary
of
Topics
MAIN POINTS
COVERED
Technology behind Steramist
Introducing BIT™
iHP™ Process
Benefits of Steramist
Competitive Advantage
Client List
Our Team
Our Values
Affiliations

3. • The technology from TOMI Environmental Solutions, Inc - SteraMist® is a
hydrogen peroxide-based mist/fog that de-activates even the toughest
pathogens without even wiping the hard surface that has been infected.
• SteraMist® BIT™ is registered with the U.S. Environmental Protection Agency
(“EPA”) as a hospital-healthcare and effective broad-spectrum surface
disinfectant.
• SteraMist® BIT™ is registered and approved by the U.S. Environmental
Protection Agency (“EPA”) as a disinfectant to kill / de-activate SARS-CoV-2
(COVID-19). EPA Registration # 90150-2.
Steramist

4. • SteraMist® BIT™ is designed to provide fast-acting biological six-log
(a 99.9999% kill) and greater in even the hardest-to-reach areas, while
leaving no residue or noxious fumes.
• Hospitals in South Korea and the United States have been heavily using TOMI
SteraMist® (List of Healthcare clients is listed on the last slide).
• Singapore Changi General Hospital currently owns 3 units.
• Singapore SCDF (Singapore's Bomba) heavily used SteraMist during peak
Covid infections. In March 2020, the mosques in Singapore were infected.
SteraMist was used to disinfect to get mosques ready for gatherings again.
Steramist

5. • Developed for first responders as a result of the 2001 United States
biological attack using weaponized anthrax known as Amerithrax.
• The US Pentagon’s Defense Advanced Research Projects Agency (DARPA) and
L-3 Communications (Formerly Titan Corp) participated in the development of
BIT™ for the purpose of neutralization of this hard to kill spore.
• Binary Ionization Technology® (BIT™) neutralizes weaponized anthrax on the
chemical suits of first responders, indoor objects/surfaces and space.
Introducing Binary
Ionization Technology® (BIT™)

6. The iHP™ (ionized Hydrogen Peroxide)
Process

7. The iHP™ (ionized Hydrogen Peroxide)
Process
Destroys proteins, carbohydrates and lipids on contact (via oxidation) which
results in killing bacteria, bacteria spores, mold spores including the
inactivation of viruses.
Reacts with chemical agents by breaking their double bond and
neutralizing them via oxidation. The same is true with weaponized
biological agents as they are neutralized via oxidation.
The by-products of ionized hydrogen peroxide (oxygen and water in the
form of humidity) are far safer to handle than those left by conventional
methods.

8. Allows a Kill on Contact – using ONLY 7.8% hydrogen peroxide-based
solution which breaks the bond- creating Reactive Oxygen Species
(ROS), composed mostly of Hydroxyl Radicals.
Six-Log Kill Achieved – NOT by a high concentration of , but by the
power in the ion of the Hydroxyl Radicals.
The Cold Plasma Arc:
Leads to a Better Decontamination Technology by Activation

9. A charged droplet is activated immediately after the solution passes the
arc - a SMALL CHARGED MICRON and a fog that disperses like a GAS
throughout an area, touching all surfaces, and completing this task
without the need of additional equipment (i.e. fans or blowers).
The Cold Plasma Arc:
Leads to a Better Decontamination Technology by Activation

10. The Six-Log Advantage

11. EPA Registered: Solution + Equipment Combination
For use as a Healthcare-Hospital Disinfectant and General Use, Multiple Use Disinfectant
Disinfects against:
Staphylococcus aureus (Staphylococcus) (Staph) (ATTC #6538)
Pseudomonas aeruginosa (Pseudomonas) (ATTC #15442)
Methicillin Resistant Staphylococcus aureus (MSRA) (ATTC #33592)
Salmonella enterica (Salmonella) (ATTC #10708)
Influenza A virus (H1N1) (ATTC #VR-1469)
Clostridium difficile spores (C. diff) (ATTC #43598)
Norovirus (Feline Calicivirus) (FCV) (ATTC #VR-782)
For use in mold and mildew control and remediation.

12. The first EPA registered solution + equipment combination that provides the
unique technology of Hydrogen Peroxide Ionization for Hospital-Healthcare
Disinfecting.
Effective against bacterial spores and gram-negative bacteria, including
multiple drug resistant organisms (MDROs).
Effective against viruses including COVID-19, SARs, MERs, swine, bird flu
and mold.
Easily incorporated into current procedures and protocols.
Fast cycle times – quick turn room turnover.
Non-corrosive, leaves no residue, proven materials compatibility, does not
damage delicate medical instrument, laboratory equipment, sensitive
electronics in ambulances or avionics in infectious disease transport
aircraft.
No blistering or paint and is Silver Ion free.
EPA Registered: Solution + Equipment Combination

13. Fully portable, hand-held, point and spray disinfection/decontamination
system.
Application time of only five (5) seconds per square foot and a seven (7)
minute contact time.
Decontaminates high touch surfaces.
Transportable and provides complete room decontamination,
deodorization and mold mitigation using multiple treatment applicators
per unit.
Effective whole complete room treatment in just under forty-five (45)
minutes for a room 3,663.7 ft3/104 m3.
Benefits of Steramist

14. The SteraMist BIT system has tested with extensive materials compatibility
studies for 39 commonly used:
Metals
Plastics
Rubbers
Tests concluded that there was no indication of material corrosion or
surface degradation for all materials tested.
Economical, non-corrosive and easy to apply
Ultimate tool for elimination of bacteria and the inactivation of viruses in
warehouses, transportation, packaging plants, labs, and over a hundred
other EPA approved verticals/use sites.
SteraMist® BIT™ Material Compatibility

15. Competitive Advantage

17. The WHO – Innovative Health Technologies
562 technologies evaluated by 35 internal WHO staff and 87
external reviewers, who presented no conflict of interest. Once the
evaluations were received and compiled, a total of 39 prototypes
and 29 commercially available products were selected and are
presented in this 2017 Compendium.
Medical devices, assistive devices and eHealth solutions are health
technologies, which have the potential to save lives and improve
quality of life and well-being. This
Compendium just illustrates some innovative technologies that
are in the pipeline and others that are available that can
empower health care workers and might support people and
patients to have a healthier life.

18. Government Clients

19. Select Hospital - Healthcare Clients

20. Life Sciences Clients

21. TOMI Steramist in Countries around the World
Steramist utilized in Singapore to help reopen Mosques
Link to Article: https://www.globenewswire.com

22. TOMI Steramist in Countries around the World
Seoul Metropolitan Subway (March 2020)

23. TOMI Steramist in Countries around the World
Seoul National University Hospital
SteraMist® BIT™ technology successfully tested on a CT scanner used on a MERS positive patient.

24. TOMI Steramist in Countries around the World
Planet Innovation in Australia

25. Thailand
Malaysia
Singapore
Indonesia
AGIOfficeLocations

26. AGI Geographical Coverage
1) Brunei
2) Cambodia
3) China
4) India
5) Indonesia
6) Malaysia
7) Maldives
8) Pakistan
9) Philippines
10) Singapore
11) South Korea
12) Sri Lanka
13) Thailand
14) Timor Leste
15) United Kingdom
16) United States of
America
17) Vietnam

27. Management
Professor Dr. M. YadavKirit Kumar Dr. Leslie

28. Kirit Kumar
CEO
Co-founded AGI in Singapore in 1985 after graduating from National University of
Singapore and grew the business internationally.
He was trained by various institutes in the USA for Indoor Air Quality and Disaster
Restoration, including Institute of Energy Engineers, US-Indoor Air Quality Council and
Institute of Inspection, and Cleaning and Restoration Certification (IICRC USA). His
specialty is in neutralising bacteria and virus from major disasters. His work has been well
researched, and the method meets the world standards, including US-EPA, CDC and
meets the WHO guidelines for micro-organism remediation.
Education
Bachelor of Business Administration
Post-graduate in Marketing Communication
Certified Indoor Air Quality Specialist (USIAQC)
IICRC Certified Restoration Specialist
Certified Indoor Air Quality Technician (Association of Energy Engineers - USA)
Water Loss Institute USA
Certification

29. Certification

30. Certification

31. Certification

32. Certification

33. Certification

34. Professor Dr. M. Yadav
Virologist
Apart from the studies on allergy, Professor Dr. Yadav also initiated a second
research interest, investigating the role of viruses in the development of Cancer. In
the early years around 1979, he established molecular and immunological detection
techniques for Epstein-Barr virus in Nasopharyngeal carcinoma (NPC). Later in 1985 he
included other viruses particularly Human Herpes virus-6, 7 and 8, and Human
Papilloma virus (HPV) in his studies of the oral and cervical carcinoma. Many papers on
aspects of the expression of oncogenes in breast cancer, and virus developmental
antigens in cervical carcinoma and oral cancer were published in international journals.
Funding for his research was from many international sources.
He has received many honours. In 1979 he was a visiting Professor to College de France
in Paris as an invitee of the French Government, and in 1979-1980 he was World Health
Organization fellow at University College, London. Dr. Yadav is the first Malaysian recipient
of Yamagiva-Yoshida memorial international award in 1983 which was spent at the
National Cancer Institute, Bethesda, and the Mayo Clinic Guggenheim Building, Rochester,
and in 1985-86 he is the first Malaysian recipient of the prestigious Eleanor-Roosevelt
International Fellowship which was taken at the National Cancer Institute Fredrick, USA.

35. Dr. Leslie Leong
Consultant, Orthopaedic Surgeon, Director of L3M
Dr. Leslie is an orthopaedic surgeon with specialisation in hip and knee surgery and
osteoporosis. Now, Dr. Leslie leads L3M International Pte. Ltd. to compliment and aide
TOMI Environmental Solutions Inc (TOMI USA) as its representative in the South East Asia
Region. As the founding member of L3M, Dr. Leslie gives much of his focus to TOMI’s
SteraMist® technology. TOMI’s SteraMist® provides a new way of sterilization or
decontamination for today’s emerging pathogens (SARS CoV-2/Covid–19) and mutating
resistant bacteria, bacteria spores, and viruses – a worthy addition to the Virus / Covid-19
Sterilization and Containment segment of AGI.
Dr Leslie Leong graduated from the National University of Singapore in 1991. He
obtained his Master of Medicine (Surgery) and Fellowship of the Royal College of
Surgeons (Edinburgh) in 1997. In 2001, he was awarded the Ministry of Health Manpower
Development Programme (HMDP) Scholarship to train at Toronto Western Hospital in
Adult Reconstruction in Hip and Knee Arthroplasty.

36. MOF Approvals

37. Our Values
Consistently Effective
Fast in Client-Focused Service
Social and Environmental Care
Tenacious Commitment to Continuous Improvement

38. Affiliations
IFE
IAAI
CFEI
FSS - UK
NFPA
RACI
IICRC
WLI
NIDR
Institute of Fire Engineers
International Association of Arson Investigators
Certified Fire and Explosion Investigators
Forensic Science Society of the UK and Malaysia
National Fire Protection Association
Royal Australian Chemical Institute
Institute of Inspection, Cleaning and Restoration Certification
Water Loss Institute
National Institute of Disaster Restoration

39. Approved Group International
@approvedgroup
@agifreeyourmind
Approved Group International
Approved Group International
@approvedgroup